Results 1 to 10 of about 18,768 (157)

Effective therapeutic targeting of CTNNB1-mutant hepatoblastoma with WNTinib. [PDF]

open access: yesMol Oncol
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Balaseviciute U   +17 more
europepmc   +2 more sources

[Metabolic Dysfunction-Associated Steatotic Liver Disease and its association with prediabetes in adolescents with obesity]. [PDF]

open access: yesRev Med Inst Mex Seguro Soc
Peralta-Cortázar C   +8 more
europepmc   +1 more source

Tracking B cell immunity during perturbation of hepatitis B infection induced by treatment withdrawal. [PDF]

open access: yesGut
Lens S   +11 more
europepmc   +1 more source

Management of Wilson disease across Europe: an international physician-oriented survey by the ERN-RARE Liver group. [PDF]

open access: yesOrphanet J Rare Dis
Kirk FT   +14 more
europepmc   +1 more source

[Infantile Hepatic Hemangioendothelio- ma with Elevated Alpha-fetoprotein: Case Report and Review]. [PDF]

open access: yesActa Gastroenterol Latinoam
Valberdi Lecce ML   +3 more
europepmc   +1 more source

[Adrenal incidentaloma with hyperprocalcitoninemia]. [PDF]

open access: yesAten Primaria
Zambudio-Munuera A   +3 more
europepmc   +1 more source

Fully robotic pancreatoduodenectomy. First procedure in Mexico

open access: yesRevista de Gastroenterología de México (English Edition), 2020
A. Cuendis-Velázquez   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy